Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1510 of 6351
-
New program aims to cut overdose risk for women leaving prison
Disease control By invitation onlyThe overall aim of this study is to reduce overdose risk for criminal legal system (CLS) involved women during community re-entry through the adaptation and testing of an innovative, trauma-informed, relational intervention approach (Trust-Based Relational Intervention or TBRI).
Sponsor: Michele Staton • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a phone app tame PTSD? new trial aims to find out
Symptom relief OngoingThis study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.
Phase 2 • Sponsor: Oui Therapeutics, Inc. • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC
-
New hope for AML patients: oral drug aims to keep remission going
Disease control OngoingThe purpose of this study is to assess real-world effectiveness and safety of oral azacitidine in adults diagnosed with acute myeloid leukemia (AML) in Hong Kong
Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Dissolvable shoulder implant offers new hope for torn rotator cuffs
Disease control Recruiting nowThe Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
Sponsor: Voll Medical Technologies Ltd. • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Can a heart scan predict who will get better? new study aims to find out
Knowledge-focused By invitation onlyBackground: Heart failure with reduced ejection fraction (HFrEF) is a heterogeneous condition with variable potential for left ventricular ejection fraction (LVEF) recovery. While LVEF improvement and reverse remodeling predict better outcomes, the determinants that predict left…
Phase 4 • Sponsor: Gødstrup Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug EDI048 takes on stomach bug in human trial
Disease control Recruiting nowThis study has the purpose to demonstrate prospect of benefit of EDI048 on clinical signs and symptoms of cryptosporidiosis to facilitate trial in target population, pediatric patients. This study aims to investigate the efficacy of a new chemical entity, EDI048, in a controlled…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New shot aims to tame dangerously high blood fats
Disease control Recruiting nowThe purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia. Participants will receive two subcutaneous injections.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Radiation may control breast cancer when surgery Isn't an option
Disease control Recruiting nowThe purpose of this study is to find out if adding radiation therapy to routine medications for breast cancer helps in reducing and preventing the cancer from getting worse. Patients with a locally advanced breast cancer who cannot, or do not want to, undergo surgery are eligible…
Sponsor: Alexander Stessin • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New camera eye could catch colon cancer early in IBD patients
Diagnosis Recruiting nowTexture and Colour Enhancement Imaging (TXI) improves texture, brightness, and colour in white-light endoscopy to highlight subtle tissue differences. Now available through the EVIS X1 system, early evidence suggests potential value in IBD. Studies show that TXI may help predict …
Sponsor: London North West Healthcare NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
Radiation boosts immunotherapy in Hard-to-Treat cancers?
Disease control Recruiting nowThis is a non-randomized two-arm trial, specifically a pilot study in which patients with advanced solid tumor cancer with 3-10 metastatic lesions who are on immunotherapy will receive ablative RT to up to 10 lesions. After study intervention, participants will undergo ctDNA coll…
Phase 1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Robotic glove plus zaps may restore hand movement in stroke survivors
Symptom relief Recruiting nowStroke is a clinically delineated syndrome, which is characterised by an acute, focal neurological deficit resulting from vascular injury (infarction or haemorrhage) within the central nervous system. Notably, around 80 percent of stroke survivors experience post-stroke deficits …
Sponsor: Lahore University of Biological and Applied Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New PET tracer aims to spot Parkinson's protein in living brains
Diagnosis Stopped earlyThis clinical study is being conducted to learn more about a new imaging drug called \[18F\]MK-0947, which is designed to help doctors see changes in the brain related to Parkinson's disease (PD). PD is a condition that affects movement, balance, and thinking. The drug works with…
Early phase 1 • Sponsor: Invicro • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
New therapy aims to break the link between childhood trauma and suicide
Symptom relief Recruiting nowThe investigators have developed a novel suicide intervention, Integrated Suicide and Trauma Therapy (ISTT). ISTT combines Brief-Skills for Safer Living (Brief-SfSL)-a promising method to enhance coping skills and reduce suicidality-with a trauma therapy component to alleviate th…
Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New hope for diabetic eyes: stronger dose may stop vision loss
Disease control OngoingThe purpose of this Phase 4 study is to evaluate the safety of aflibercept 8mg in patients with proliferative diabetic retinopathy without center-involved diabetic macular edema.
Phase 4 • Sponsor: Edward Wood, MD • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a common drug reverse Poison-Induced delirium? new study says yes
Symptom relief CompletedThis study aims to evaluate the clinical efficacy and safety of rivastigmine in reversing the full spectrum of anticholinergic delirium including hypoactive delirium which is presented with CNS depression and hyperactive or agitated delirium. The study was conducted on 100 patie…
Phase 4 • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Pakistan launches largest School-Based obesity prevention trial for kids
Prevention Recruiting nowChildhood obesity is increasing rapidly in Pakistan, but there are no large, high-quality studies testing ways to prevent it in schools. This study aims to find out if a 9-month program involving health education, daily physical activity, parent workshops, and regular feedback vi…
Sponsor: Central South University • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
Can antibiotics trigger Kidney-Harming crystals? a study investigates
Knowledge-focused Recruiting nowThis study examines in hospitalized patients, treated with sulfamethoxazole, high dose ciprofloxacin or high dose iv amoxicillin, the incidence of drug-induced urinary crystal formation and its association with acute kidney injury development.
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New hope for endometriosis pain: hormone pill targets inflammation
Disease control Recruiting nowThe purpose of this study is to better understand how hormone suppression with Relugolix Combination-Therapy (CT) affects pelvic pain, inflammation, and pain sensitivity in women with moderate-to-severe endometriosis associated pelvic pain.
Phase 3 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for Hard-to-Treat ovarian cancer: drug combo enters human testing
Disease control Recruiting nowThe purpose of this study is to learn about the safety and tolerability of Cirtuvivint in combination with Olaparib in platinum resistant ovarian cancer. The study also aims to determine the recommended dose of the combination therapy. If a participant is a good fit for the stud…
Phase 1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Nurses take the lead: could nurse-led methadone dosing keep more people in treatment?
Disease control Recruiting nowInitiations of methadone treatment for opiode use disorder (OUD) are carried out in France in specialized centers, known as centers for care, support and prevention in addictology (CSAPA) In this way, hospital practitioners initiate the prescription of methadone, which is deliver…
Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC